Fig. 6
Different ADCmax and ADCmin values of lesions treated with NAT + RH (a–b) and CCRT (c–d); the maximum slice of the primary tumor was showed on T2W(a1-d1), DWI(a2-d2) and ADC(a3-d3) map. a1–3 A 51-year-old patient treated with NAT + RH, the ADCmin of the primary tumor was 0.552 × 10−3mm2/s, DFS was 11.23 months; b1–3 a 45-year-old patient treated with NAT + RH, the ADCmin of the primary tumor was 0.685 × 10−3mm2/s, DFS was 68.90 months; c1–3 a 48-year-old patient treated with CCRT, the ADCmax of the primary tumor was 1.130 × 10−3mm2/s, DFS was 10.70 months; d1–3 a 48-year-old patient treated with CCRT, the ADCmax of the primary tumor was 0.977 × 10−3mm2/s, DFS was 35.50 months. NAT + RH, neoadjuvant therapy followed by radical hysterectomy; CCRT, concurrent chemoradiation; DFS, disease-free survival